STAT+: Medicare’s miss on Alzheimer’s drug spending

This is the online version of STAT’s weekly email newsletter Health Care Inc.&#x A0;Sign up here. Did you know the U.S. Mint requires gold coins to be made with American-made gold, but instead it gets illegally mined gold that can be traced back to a Colombian drug cartel? Truly mind-blowing stuff from this New York Times investigation. Let me know what the health care angle is on that one: bob.herman@statnews.com. It’s tough to make predictions, especially about the future Two years ago, my old pal Rachel Cohrs Zhang and I reported how Medicare’s actuaries predicted the new Alzheimer’s drug Leqembi would cost the program $3.5 billion in 2025. It turns out that prediction was way off.Continue to STAT+ to read the full story…